1. Home
  2. TELO vs SURG Comparison

TELO vs SURG Comparison

Compare TELO & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • SURG
  • Stock Information
  • Founded
  • TELO 2021
  • SURG 2006
  • Country
  • TELO United States
  • SURG United States
  • Employees
  • TELO N/A
  • SURG N/A
  • Industry
  • TELO
  • SURG Advertising
  • Sector
  • TELO
  • SURG Consumer Discretionary
  • Exchange
  • TELO NYSE
  • SURG Nasdaq
  • Market Cap
  • TELO 58.6M
  • SURG 56.5M
  • IPO Year
  • TELO 2024
  • SURG N/A
  • Fundamental
  • Price
  • TELO $1.53
  • SURG $3.07
  • Analyst Decision
  • TELO
  • SURG Strong Buy
  • Analyst Count
  • TELO 0
  • SURG 1
  • Target Price
  • TELO N/A
  • SURG $9.00
  • AVG Volume (30 Days)
  • TELO 408.8K
  • SURG 108.0K
  • Earning Date
  • TELO 08-12-2025
  • SURG 08-12-2025
  • Dividend Yield
  • TELO N/A
  • SURG N/A
  • EPS Growth
  • TELO N/A
  • SURG N/A
  • EPS
  • TELO N/A
  • SURG N/A
  • Revenue
  • TELO N/A
  • SURG $40,029,467.00
  • Revenue This Year
  • TELO N/A
  • SURG $57.76
  • Revenue Next Year
  • TELO N/A
  • SURG $112.61
  • P/E Ratio
  • TELO N/A
  • SURG N/A
  • Revenue Growth
  • TELO N/A
  • SURG N/A
  • 52 Week Low
  • TELO $1.52
  • SURG $1.05
  • 52 Week High
  • TELO $8.40
  • SURG $3.47
  • Technical
  • Relative Strength Index (RSI)
  • TELO 29.64
  • SURG 58.30
  • Support Level
  • TELO $1.65
  • SURG $2.64
  • Resistance Level
  • TELO $1.81
  • SURG $2.95
  • Average True Range (ATR)
  • TELO 0.17
  • SURG 0.21
  • MACD
  • TELO -0.01
  • SURG 0.03
  • Stochastic Oscillator
  • TELO 1.03
  • SURG 60.98

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

Share on Social Networks: